{
    "summary": "The bill, titled the \"Maintaining Investments in New Innovation Act,\" aims to amend Title XI of the Social Security Act regarding access to genetically targeted technologies. It modifies the definition of a \"qualifying single source drug\" to extend the period for which advanced drug products, utilizing genetically targeted technologies, are protected. This involves defining \"advanced drug product\" and relating it to gene modulation technologies.",
    "tags": [
        "Healthcare",
        "Social security",
        "Technology regulation",
        "Healthcare access"
    ],
    "category": "Healthcare & Public Health"
}